4.7 Editorial Material

C3 nephritic factors: A changing landscape

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 140, Issue 1, Pages 57-59

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2017.02.018

Keywords

C3 nephritic factor; alternative complement activation; membranoproliferative glomerulonephritis; C3 glomerulopathy; dense-deposit disease; partial lipodystrophy; eculizumab

Funding

  1. DUET Trial
  2. SHIPAHOY
  3. NEPTUNE II
  4. CureGN
  5. National Institutes of Health
  6. Lupus Foundation of American
  7. Alliance for Lupus Research
  8. American Academy of Allergy, Asthma Immunology

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available